PSG Versus Oxim-capnography to Setup Home NIV

NCT ID: NCT02444806

Last Updated: 2016-07-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to compare 2 different strategies used to setup non-invasive ventilation in patients with OCPD-OSA overlap.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With limited comparative data to support the different strategies, there is substantial variation across Europe and the United States in the methods used by clinicians to set up home non-invasive ventilation (NIV) for patients with chronic respiratory failure as a consequence of sleep disordered breathing. Indeed with few data to support the practice, many centres employ full montage polysomnography, which is not only a significant physical burden to the patient but also a financial burden to the healthcare provider in terms of the facilities required, staff training and equipment.

The investigators propose to undertake a randomised controlled trial to compare the clinical effectiveness, in terms of the change in daytime arterial partial pressure of carbon dioxide (PaCO2) at 3 months, of limited respiratory polygraphy and full polysomnography to set up NIV in patients with COPD-OSA overlap. Secondary outcome measures at 3 months will include overnight control of gas exchange, subjective sleep quality, health related quality of life and ventilator adherence. COPD-OSA overlap are a patient group that have a rising prevalence with limited data currently available detailing NIV set up, which wholly supports the rationale of using this increasingly important group as a target population for this trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD OSA

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Full Polysomnography

Patients will have NIV settings established using overnight full polysomnography.

Group Type ACTIVE_COMPARATOR

Full polysomnography

Intervention Type OTHER

Full sleep and respiratory monitoring with EEG

Oximetry-capnography

Patients will have NIV settings established using only Oximetry-capnography and subjective sleep comfort.

Group Type ACTIVE_COMPARATOR

Oximetry-capnography

Intervention Type OTHER

Limited monitoring with nurse observation and continuous oximetry-capnography overnight for NIV titration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Full polysomnography

Full sleep and respiratory monitoring with EEG

Intervention Type OTHER

Oximetry-capnography

Limited monitoring with nurse observation and continuous oximetry-capnography overnight for NIV titration.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Polysomnography Limited respiratory monitoring

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD (as defined by GOLD criteria\[4\])
* OSA (ODI \> 7.5 events/hr, AHI \> 5events/hr)
* PaCO2 \> 6 kPa
* BMI \> 30 kg/m2

Exclusion Criteria

* Decompensated respiratory failure (pH \< 7.35)
* Inability to tolerate NIV (\< 4 hours usage at in hospital titration)
* Contraindication to NIV
* Pregnancy
* Aged \<18
* Significant physical or psychiatric co-morbidity that would prevent compliance with trial protocol
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Rouen

OTHER

Sponsor Role collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

References

Explore related publications, articles, or registry entries linked to this study.

Patout M, Arbane G, Cuvelier A, Muir JF, Hart N, Murphy PB. Polysomnography versus limited respiratory monitoring and nurse-led titration to optimise non-invasive ventilation set-up: a pilot randomised clinical trial. Thorax. 2019 Jan;74(1):83-86. doi: 10.1136/thoraxjnl-2017-211067. Epub 2018 Mar 30.

Reference Type DERIVED
PMID: 29602814 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14/LO/2088

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.